Article Information
History
- January 19, 2023.
Article Versions
- Version 1 (January 18, 2023 - 07:49).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Cristina Morciano1,*,
- Stefania Spila Alegiani1,*,
- Francesca Menniti Ippoliti1,
- Valeria Belleudi2,
- Gianluca Trifirò3,
- Giovanna Zanoni4,
- Aurora Puccini5,
- Ester Sapigni5,
- Nadia Mores6,
- Olivia Leoni7,
- Giuseppe Monaco7,
- Elena Clagnan8,
- Cristina Zappetti9,
- Emanuela Bovo10,
- Roberto Da Cas1 and
- Marco Massari1,§
- 1Pharmacoepidemiology and Pharmacosurveillance Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy
- 2Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy
- 3Department of Diagnostics and Public Health, University of Verona, Verona, Italy
- 4Immunology Unit, University Hospital, Verona, Italy
- 5Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy
- 6Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy
- 7Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy
- 8Regional Health Coordination Company, Udine, Italy
- 9Central Directorate for Health, Social Policies, Friuli Venezia Giulia Region, Trieste, Italy
- 10Veneto Tumour Registry, Azienda Zero, Padova, Italy
- ↵§corresponding author marco.massari{at}iss.it
↵* Contributed equally to this work as first authors
Posted January 19, 2023.
Post-marketing active surveillance of Guillan Barré Syndrome following vaccination with anti-COVID-19 vaccines in persons aged ≥12 years in Italy: a multi-database self-controlled case series study
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos